Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version

Masatoshi Kudo, Namiki Izumi, Norihiro Kokudo, Osamu Matsui, Michiie Sakamoto, Osamu Nakashima, Masamichi Kojiro, Masatoshi Makuuchi

Research output: Contribution to journalArticle

495 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.

Original languageEnglish
Pages (from-to)339-364
Number of pages26
JournalDigestive Diseases
Volume29
Issue number3
DOIs
Publication statusPublished - 2011 Aug

Fingerprint

Gastroenterology
Practice Guidelines
Hepatocellular Carcinoma
Japan
Guidelines
Evidence-Based Practice
Liver Diseases
Cause of Death
Pathology
Liver
Health
Neoplasms
Therapeutics

Keywords

  • Clinical practice guidelines
  • Clinical practice manual
  • Consensus-based
  • Diagnostic algorithm
  • Evidence-based
  • Hepatocellular carcinoma
  • Prevention
  • Staging
  • Surveillance
  • Treatment algorithm

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Management of hepatocellular carcinoma in Japan : Consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version. / Kudo, Masatoshi; Izumi, Namiki; Kokudo, Norihiro; Matsui, Osamu; Sakamoto, Michiie; Nakashima, Osamu; Kojiro, Masamichi; Makuuchi, Masatoshi.

In: Digestive Diseases, Vol. 29, No. 3, 08.2011, p. 339-364.

Research output: Contribution to journalArticle

Kudo, Masatoshi ; Izumi, Namiki ; Kokudo, Norihiro ; Matsui, Osamu ; Sakamoto, Michiie ; Nakashima, Osamu ; Kojiro, Masamichi ; Makuuchi, Masatoshi. / Management of hepatocellular carcinoma in Japan : Consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version. In: Digestive Diseases. 2011 ; Vol. 29, No. 3. pp. 339-364.
@article{80ab538215a14b3b9e74e8d291bdc864,
title = "Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version",
abstract = "Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.",
keywords = "Clinical practice guidelines, Clinical practice manual, Consensus-based, Diagnostic algorithm, Evidence-based, Hepatocellular carcinoma, Prevention, Staging, Surveillance, Treatment algorithm",
author = "Masatoshi Kudo and Namiki Izumi and Norihiro Kokudo and Osamu Matsui and Michiie Sakamoto and Osamu Nakashima and Masamichi Kojiro and Masatoshi Makuuchi",
year = "2011",
month = "8",
doi = "10.1159/000327577",
language = "English",
volume = "29",
pages = "339--364",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Management of hepatocellular carcinoma in Japan

T2 - Consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version

AU - Kudo, Masatoshi

AU - Izumi, Namiki

AU - Kokudo, Norihiro

AU - Matsui, Osamu

AU - Sakamoto, Michiie

AU - Nakashima, Osamu

AU - Kojiro, Masamichi

AU - Makuuchi, Masatoshi

PY - 2011/8

Y1 - 2011/8

N2 - Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.

AB - Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.

KW - Clinical practice guidelines

KW - Clinical practice manual

KW - Consensus-based

KW - Diagnostic algorithm

KW - Evidence-based

KW - Hepatocellular carcinoma

KW - Prevention

KW - Staging

KW - Surveillance

KW - Treatment algorithm

UR - http://www.scopus.com/inward/record.url?scp=80051758429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051758429&partnerID=8YFLogxK

U2 - 10.1159/000327577

DO - 10.1159/000327577

M3 - Article

C2 - 21829027

AN - SCOPUS:80051758429

VL - 29

SP - 339

EP - 364

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - 3

ER -